Adult ADHD Statistics: What the Current U.S. Data Show
- Aug 25
- 2 min read
Adult ADHD is discussed constantly online, but many statistics are repeated without a date or source. The numbers below come from recent CDC and NCHS reports. This page was updated in August 2026; the principal prevalence and treatment estimates are based on 2023 data.
The headline numbers
6.0% of U.S. adults were estimated to have a current ADHD diagnosis in 2023—about 15.5 million adults, or roughly 1 in 16.
55.9% of adults with current ADHD reported first receiving the diagnosis at age 18 or older.
50.4% reported being prescribed ADHD medication during the prior 12 months.
36.5% reported receiving neither ADHD medication nor counseling or behavioral treatment during the prior year.
71.5% of adults taking stimulant ADHD medication reported difficulty filling a prescription because the medication was unavailable.
46.0% reported ever receiving telehealth services for ADHD.
What the newer health-center data add
A separate National Center for Health Statistics report, published in December 2025 using 2023 health-center data, reinforces an important clinical point: adult ADHD often appears alongside other psychiatric and medical conditions.
Nearly 70% of adult ADHD health-center visits included at least one selected co-diagnosed mental health condition.
40.1% included at least one selected non-psychiatric chronic condition.
54.6% had a documented prescription for at least one selected ADHD medication.
The prevalence numbers argue against dismissing adult ADHD. The comorbidity numbers argue against diagnosing it casually.
Why adult diagnosis is common
The finding that more than half of adults with current ADHD reported being diagnosed after age 18 does not mean ADHD begins in adulthood. ADHD is a neurodevelopmental disorder. The statistic shows how often recognition and formal diagnosis happen later, sometimes after years of compensation.
That is why adult evaluation depends on developmental history and functional patterns, not current symptoms alone.
What about national adult ADHD guidelines?
As of August 2026, finalized U.S. adult ADHD clinical practice guidelines have not yet been released. APSARD is leading development of the first U.S. adult ADHD guidelines, with work organized around diagnosis, medical treatment, and psychosocial interventions. CHADD states that it is participating in the effort and anticipates guideline development and distribution in 2027.
For journalists and educators
The statistics on this page link directly to their primary sources so they can be verified in context. If you cite the clinical interpretation here, attribution to John Lee, MD and a link to this article are appreciated.